Does “Birth” as an Event Impact Maturation Trajectory of Renal Clearance via Glomerular Filtration? Reexamining Data in Preterm and Full‐Term Neonates by Avoiding the Creatinine Bias-Reference-Cited by-同舟云学术

Does “Birth” as an Event Impact Maturation Trajectory of Renal Clearance via Glomerular Filtration? Reexamining Data in Preterm and Full‐Term Neonates by Avoiding the Creatinine Bias

Published:2020-09-03 Issue:2 Volume:61 Page:159-171
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharmacology

Author:

Salem Farzaneh¹,Johnson Trevor N.¹,Hodgkinson Arran B. J.¹,Ogungbenro Kayode²,Rostami‐Hodjegan Amin¹²

Affiliation:

1. Certara UK Ltd, Simcyp Division Sheffield UK

2. Centre for Applied Pharmacokinetic Research Division of Pharmacy and Optometry School of Health Sciences Faculty of Biology Medicine and Health Manchester Academic Health Science Centre University of Manchester Manchester UK

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcph.1725

Reference65 articles.

1. Limited predictability of amikacin clearance in extreme premature neonates at birth

2. Covariates of Amikacin Clearance in Neonates: The Impact of Postnatal Age on Predictability

3. Individualised dosing of amikacin in neonates: a pharmacokinetic/pharmacodynamic analysis

4. Population pharmacokinetics of gentamicin in South African newborns

5. A Gentamicin Pharmacokinetic Population Model and Once-Daily Dosing Algorithm for Neonates

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Physiologically-Based Pharmacokinetic Modeling and Dosing Optimization of Cefotaxime in Preterm and Term Neonates;Journal of Pharmaceutical Sciences;2024-08

2. Pharmacometric in silico studies used to facilitate a national dose standardisation process in neonatology – application to amikacin;Swiss Medical Weekly;2024-04-08

3. Bayesian Vancomycin Model Selection for Therapeutic Drug Monitoring in Neonates;Clinical Pharmacokinetics;2024-02-28

4. Neonatal Pharmacology;Avery's Diseases of the Newborn;2024

5. Physiologically Based Pharmacokinetics Modeling in the Neonatal Population—Current Advances, Challenges, and Opportunities;Pharmaceutics;2023-11-03